Morocco's Sothema Receives Three Cannabis-Based Epilepsy Drug Authorizations
Sothema reportedly received marketing authorizations for three cannabis-based epilepsy medicines. Final distribution requirements remained and names, exact formulations, prices and launch dates were undisclosed. This is a regulatory milestone, not immediate pharmacy availability or new efficacy evidence.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
newsweed.fr
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://www.newsweed.fr/en/morocco-three-medications-for-epilepsy-using-cannabis/